{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:00:52Z","timestamp":1790128852680,"version":"4.0.1"},"reference-count":272,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jconrel.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T05:23:07Z","timestamp":1628400187000},"page":"80-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Nanomedicine based approaches for combating viral infections"],"prefix":"10.1016","volume":"338","author":[{"given":"Saurabh","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahavir Bhupal","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Kotha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Kashikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Singh","family":"Raghuvanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bala","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.08.011_bb0005","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1098\/rstb.2004.1480","article-title":"Environmental and social influences on emerging infectious diseases: past, present and future","author":"McMichael","year":"2004","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0010","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: how we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5152\/tjg.2017.20817","article-title":"The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"28","author":"Idilman","year":"2017","journal-title":"Turkish J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234740","article-title":"Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium","volume":"15","author":"Koc","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virusres.2015.01.021","article-title":"Middle East respiratory syndrome: an emerging coronavirus infection tracked by the crowd","volume":"202","author":"Mackay","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0030","author":"WHO Coronavirus (COVID-19) Dashboard"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0035","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/S2214-109X(19)30545-5","article-title":"Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Glob. Heal."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2019.114876","article-title":"The risk factors associated with MERS-CoV patient fatality: a global survey","volume":"96","author":"Ahmadzadeh","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0050","series-title":"Novel Technologies for Vaccine Development","author":"Lukashevich","year":"2014"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.18433\/J39W2G","article-title":"New perspectives on innovative drug discovery: an overview","volume":"13","author":"Pan","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.epidem.2019.100356","article-title":"Improved inference of time-varying reproduction numbers during infectious disease outbreaks","volume":"29","author":"Thompson","year":"2019","journal-title":"Epidemics"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0065","article-title":"Nanotechnology-based antiviral therapeutics","author":"Chakravarty","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0070","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1021\/acssensors.0c01961","article-title":"Two-dimensional material-based biosensors for virus detection","volume":"5","author":"M\u00e9nard-Moyon","year":"2020","journal-title":"ACS Sens."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0075","series-title":"Mol. Virol. Hum. Pathog. Viruses","first-page":"3","article-title":"Discovery and classification","author":"Ryu","year":"2017"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.tim.2020.08.003","article-title":"Investigating the concept and origin of viruses","volume":"28","author":"Nasir","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.virusres.2019.02.006","article-title":"Early events in rabies virus infection\u2014attachment, entry, and intracellular trafficking","volume":"263","author":"Guo","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0090","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","article-title":"In vivo tissue-tropism of adeno-associated viral vectors","volume":"21","author":"Srivastava","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1201\/9781315159768-15","article-title":"Innate and adaptive barrier properties of airway mucus","author":"Schaefer","year":"2019","journal-title":"Inhal. Aerosols"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2019.10.035","article-title":"Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy","volume":"314","author":"He","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.it.2020.03.002","article-title":"Helper-like innate lymphoid cells in humans and mice","volume":"41","author":"Guia","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-981-15-6255-6_10","article-title":"Advances in pulmonary nanomedicine for therapeutic management of respiratory diseases","author":"Ray","year":"2020","journal-title":"Nano Med. Nano Saf."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/B978-0-12-815272-0.00014-3","article-title":"Main microbiological pollutants of bottled waters and beverages","author":"Curutiu","year":"2019","journal-title":"Bottl. Packag. Water"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-immunol-031210-101317","article-title":"Immunoglobulin responses at the mucosal interface","volume":"29","author":"Cerutti","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","article-title":"The role of mast cells in functional GI disorders","volume":"65","author":"Wouters","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0140","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/1462-2920.13926","article-title":"Host-microbe interaction in the gastrointestinal tract","volume":"20","author":"Parker","year":"2018","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01995","article-title":"Role of short chain fatty acids in controlling Tregs and immunopathology during mucosal infection","volume":"9","author":"Bhaskaran","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.it.2018.02.003","article-title":"Innate antiviral immunity in the skin","volume":"39","author":"Handfield","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri1860","article-title":"Defensins in innate antiviral immunity","volume":"6","author":"Klotman","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0160","series-title":"Slatter\u2019s Fundam. Vet. Ophthalmol","first-page":"157","article-title":"Lacrimal system","author":"Miller","year":"2008"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0165","series-title":"Lacrimal Syst. Diagnosis, Manag. Surg","first-page":"1","article-title":"Anatomy of the lacrimal system","author":"Burkat","year":"2015"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0170","series-title":"Cambridge Handb. Psychol. Heal. Med","first-page":"875","article-title":"Sexually transmitted infections","author":"Hedge","year":"2014"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0175","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/acs.bioconjchem.0c00395","article-title":"Dendrimers toward translational nanotherapeutics: concise key step analysis","volume":"31","author":"Mignani","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0180","doi-asserted-by":"crossref","first-page":"100406","DOI":"10.1016\/j.colcom.2021.100406","article-title":"Exploring the unexplored avenues of surface charge in nano-medicine","volume":"42","author":"Shah","year":"2021","journal-title":"Colloid Interf. Sci. Commun."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2015.10.008","article-title":"Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier","volume":"38","author":"Miner","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00042","article-title":"How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication","volume":"9","author":"Eisenreich","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrmicro817","article-title":"Virus entry: Molecular mechanisms and biomedical applications","volume":"2","author":"Dimitrov","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0200","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191077","article-title":"Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2\u2013E1 dissociation during viral entry","volume":"39","author":"Sahoo","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0205","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molcel.2010.02.012","article-title":"Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions","volume":"37","author":"Finzi","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0210","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1128\/JVI.03101-14","article-title":"Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry","volume":"89","author":"Strauss","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0215","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ceb.2009.03.008","article-title":"Viruses and endosome membrane dynamics","volume":"21","author":"Gruenberg","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0225","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1146\/annurev-biochem-060208-104626","article-title":"Virus entry by endocytosis","volume":"79","author":"Mercer","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0230","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1021\/acs.chemrev.9b00692","article-title":"Single-virus tracking: from imaging methodologies to virological applications","volume":"120","author":"Liu","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tim.2018.06.008","article-title":"Exploitation of cytoskeletal networks during early viral infection","volume":"27","author":"Walsh","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0240","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bbamcr.2010.12.009","article-title":"How viruses access the nucleus","volume":"1813","author":"Cohen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0245","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1021\/acs.jproteome.0c00623","article-title":"Structural insights into the binding modes of Viral RNA-dependent RNA polymerases using a function-site interaction fingerprint method for RNA virus drug discovery","volume":"19","author":"Zhao","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8420","article-title":"Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro","volume":"370","author":"Christensen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0255","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00705-017-3497-8","article-title":"A comparative review of viral entry and attachment during large and giant dsDNA virus infections","volume":"162","author":"Sobhy","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0260","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins \u03b1v\u03b23 and \u03b1v\u03b25 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1571","article-title":"Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion","volume":"2","author":"Zhang","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0270","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1128\/JVI.01673-08","article-title":"Molecular basis of the interaction between complement receptor type 2 (CR2\/CD21) and epstein-barr virus glycoprotein gp350","volume":"82","author":"Young","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0275","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1073\/pnas.97.16.9026","article-title":"Energetics of the HIV gp120-CD4 binding reaction","volume":"97","author":"Myszka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0280","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/ijms15022892","article-title":"NTCP and beyond: opening the door to unveil hepatitis B virus entry","volume":"15","author":"Watashi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0285","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry","volume":"285","author":"Harris","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0290","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0295","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0092-8674(89)90688-0","article-title":"The major human rhinovirus receptor is ICAM-1","volume":"56","author":"Greve","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0300","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.77.8.4827-4835.2003","article-title":"Complexes of poliovirus serotypes with their common cellular receptor, CD155","volume":"77","author":"He","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0305","article-title":"Breaking the convention: sialoglycan variants, coreceptors, and alternative receptors for influenza A virus entry","volume":"94","author":"Karakus","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0310","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/1873-3468.12089","article-title":"Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions","volume":"590","author":"Zhao","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/v10050233","article-title":"Probing molecular insights into Zika virus\u2013host interactions","volume":"10","author":"Lee","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0320","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1371\/journal.ppat.0030183","article-title":"Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E","volume":"3","author":"Avirutnan","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0325","series-title":"Innate Immun. Heal. Dis. [Working Title]","article-title":"Immune dysfunction and antiretroviral therapy challenges in children and adolescents living with human immunodeficiency virus","author":"Said","year":"2020"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0330","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1590\/S0034-89102010000400019","article-title":"Quality of life and adherence to HAART in HIV-infected patients","volume":"44","author":"Geocze","year":"2010","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0335","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0340","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/17425247.3.5.613","article-title":"Nanoparticulate drug carriers for delivery of HIV\/AIDS therapy to viral reservoir sites","volume":"3","author":"Vyas","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0345","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00044011-200828060-00005","article-title":"Current and future antiretroviral treatment options in paediatric HIV infection","volume":"28","author":"Giaquinto","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0350","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12098-007-0028-8","article-title":"Adherence to High Activity Antiretrovial Therapy (HAART) in pediatric patients infected with HIV: issues and interventions","volume":"74","author":"Shah","year":"2007","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0355","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0360","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14787210.2019.1635009","article-title":"Broad-spectrum antiviral agents: a crucial pandemic tool","volume":"17","author":"Adalja","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0365","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0370","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1080\/07391102.2019.1625443","article-title":"Mechanism of resistance to acyclovir in thymidine kinase mutants from Herpes simplex virus type 1: a computational approach","volume":"38","author":"Rabelo","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0375","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2009.11.055","article-title":"Resistance to direct antiviral agents in patients with hepatitis C virus infection","volume":"138","author":"Sarrazin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0385","doi-asserted-by":"crossref","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 antiretroviral resistance: scientific principles and clinical applications","volume":"72","author":"Tang","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0390","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-405880-4.00006-8","article-title":"Influenza virus resistance to antiviral therapy","author":"van der Vries","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0395","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jhep.2015.08.010","article-title":"Management of direct-acting antiviral agent failures","volume":"63","author":"Buti","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0400","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0405","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2009.11.019","article-title":"Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs","volume":"62","author":"Sharma","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0410","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1517\/17425247.2012.697055","article-title":"Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach","volume":"9","author":"Dahan","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0415","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jps.21047","article-title":"Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting","volume":"97","author":"Li","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0420","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/ceo.12785","article-title":"Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents","volume":"44","author":"Tsatsos","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0425","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0430","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0168-3659(01)00277-2","article-title":"Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C","volume":"72","author":"Kozlowski","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0435","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cct.2004.08.003","article-title":"Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders","volume":"25","author":"Lee","year":"2004","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020171","article-title":"Nanomaterials designed for antiviral drug delivery transport across biological barriers","volume":"12","author":"Cojocaru","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0445","article-title":"The potential of long-acting, tissue-targeted synthetic nanotherapy for delivery of antiviral therapy against HIV infection","volume":"12","author":"Andersen","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0450","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cid\/civ973","article-title":"Drug-drug interactions with novel all oral interferon-free antiviral agents in a large real-world cohort","volume":"62","author":"Siederdissen","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0455","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrgastro.2013.106","article-title":"Drug-drug interactions during antiviral therapy for chronic hepatitis C","volume":"10","author":"Kiser","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0460","doi-asserted-by":"crossref","first-page":"1800054","DOI":"10.1002\/adtp.201800054","article-title":"Pharmaceutical approaches to HIV treatment and prevention","volume":"1","author":"Yavuz","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0465","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119706","article-title":"Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications","volume":"232","author":"Cheng","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0475","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425247.2013.751370","article-title":"Targeted drug delivery to macrophages","volume":"10","author":"Jain","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0480","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/btm2.10047","article-title":"Tunable particles alter macrophage uptake based on combinatorial effects of physical properties","volume":"2","author":"Garapaty","year":"2017","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0485","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1016\/j.biomaterials.2012.02.033","article-title":"A review of glycosylated carriers for drug delivery","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0490","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10611860802475688","article-title":"Lymphatic targeting of zidovudine using surface-engineered liposomes","volume":"16","author":"Kaur","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2018.04.001","article-title":"Effects of cationic liposomes with stearylamine against virus infection","volume":"543","author":"Tahara","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0500","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1039\/C8TB00967H","article-title":"The great escape: how cationic polyplexes overcome the endosomal barrier","volume":"6","author":"Bus","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0505","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acsnano.7b07583","article-title":"Endosomal size and membrane leakiness influence proton sponge-based rupture of endosomal vesicles","volume":"12","author":"Vermeulen","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0510","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biochi.2019.02.012","article-title":"Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles","volume":"160","author":"Ahmad","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0515","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1074\/jbc.272.4.2382","article-title":"Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo","volume":"272","author":"Slepushkin","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0520","first-page":"157","article-title":"Magnetic nanoformulation of azidothymidine 5\u2032-triphosphate for targeted delivery across the blood-brain barrier","volume":"5","author":"Saiyed","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-016-0236-0","article-title":"Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse","volume":"9","author":"Sagar","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0530","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/QAD.0b013e32830efd96","article-title":"N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery","volume":"22","author":"Pollock","year":"2008","journal-title":"Aids."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0535","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.colsurfb.2017.07.085","article-title":"Immunoliposomes: a review on functionalization strategies and targets for drug delivery","volume":"159","author":"Eloy","year":"2017","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0540","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2014.11.021","article-title":"Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs - modern Trojan horses to combat HIV","volume":"89","author":"Ramana","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0545","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0005-2736(01)00432-1","article-title":"Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes","volume":"1558","author":"Gagne\u00e9","year":"2002","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0550","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0264-410X(00)00163-8","article-title":"In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity","volume":"19","author":"Ludewig","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0555","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.colsurfb.2014.09.029","article-title":"Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery","volume":"123","author":"Eloy","year":"2014","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0560","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","article-title":"Niosomes from 80s to present: the state of the art","volume":"205","author":"Marianecci","year":"2014","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0565","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/03639045.2011.592529","article-title":"Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir","volume":"38","author":"Akhter","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0570","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0575","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0580","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1631\/jzus.B0820047","article-title":"Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy","volume":"9","author":"Xing-Guo","year":"2008","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0585","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.rvsc.2009.06.010","article-title":"Yak interferon-alpha loaded solid lipid nanoparticles for controlled release","volume":"88","author":"Li","year":"2010","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0590","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s11095-008-9615-2","article-title":"Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line","volume":"25","author":"Chattopadhyay","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0595","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18433\/J3XK53","article-title":"Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis b surface antigen for vaccination using subcutaneous route","volume":"13","author":"Mishra","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0600","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jps.21020","article-title":"pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute","volume":"97","author":"Choi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0605","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/03639040802130061","article-title":"Lipid nanoparticles with a solid matrix (SLN\u00ae, NLC\u00ae, LDC\u00ae) for oral drug delivery","volume":"34","author":"Muchow","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0615","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0620","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08982104.2010.539186","article-title":"Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain","volume":"21","author":"Kasongo","year":"2011","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0625","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/03639045.2010.516264","article-title":"Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex","volume":"37","author":"Wa Kasongo","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0630","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2012.12.021","article-title":"Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier","volume":"166","author":"Beloqui","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0635","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/QAI.0b013e3182653c1f","article-title":"Enhanced anti-HIV efficacy of indinavir after inclusion in CD4-targeted lipid nanoparticles","volume":"61","author":"Endsley","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0640","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41578-019-0161-9","article-title":"Multiple nanoemulsions","volume":"5","author":"Sheth","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0645","article-title":"Anti-inflammatory and skin barrier repair effects of topical application of some plant oils","volume":"19","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0650","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.colsurfb.2018.11.057","article-title":"Enhanced oral bioavailability and brain uptake of Darunavir using lipid nanoemulsion formulation","volume":"175","author":"Desai","year":"2019","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0655","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/10837450.2019.1646757","article-title":"Development and in vivo evaluation of baicalin-loaded W\/O nanoemulsion for lymphatic absorption","volume":"24","author":"Xu","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020046","article-title":"Acyclovir-loaded chitosan nanospheres from nano-emulsion templating for the topical treatment of herpesviruses infections","volume":"10","author":"Donalisio","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0665","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ijpharm.2014.08.001","article-title":"Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation","volume":"473","author":"Clares","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0670","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/21691401.2020.1725023","article-title":"Antiviral activity of curcumin-nanoemulsion associated with photodynamic therapy in vulvar cell lines transducing different variants of HPV-16","volume":"48","author":"do Bonfim","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0675","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/2211738507666191210163408","article-title":"Antiviral action of curcumin encapsulated in nanoemulsion against four serotypes of dengue virus","volume":"8","author":"Nabila","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0680","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1208\/s12249-017-0828-8","article-title":"Topical delivery of coumestrol from lipid nanoemulsions thickened with hydroxyethylcellulose for antiherpes treatment","volume":"19","author":"Argenta","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0685","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","article-title":"Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations","volume":"347","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0690","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/095632020001100104","article-title":"Prevention of murine influenza A virus pneumonitis by surfactant nano-emulsions","volume":"11","author":"Donovan","year":"2000","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0695","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0001-706X(03)00120-7","article-title":"Inactivation of Ebola virus with a surfactant nanoemulsion","volume":"87","author":"Chepurnov","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0700","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/17425247.2012.719870","article-title":"Potentials and challenges in self-nanoemulsifying drug delivery systems","volume":"9","author":"Khan","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0705","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/17425247.2017.1360863","article-title":"Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections","volume":"15","author":"Lembo","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12121194","article-title":"Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery","volume":"12","author":"Buya","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0715","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13346-014-0191-1","article-title":"Development and optimization of solid self-nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe\u2019s design for improvement of oral bioavailability of nelfinavir mesylate","volume":"4","author":"Patel","year":"2014","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0720","doi-asserted-by":"crossref","DOI":"10.1186\/1742-6405-10-14","article-title":"The utility of self-emulsifying oil formulation to improve the poor solubility of the anti HIV drug CSIC","volume":"10","author":"Obitte","year":"2013","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0725","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1389200219666171207120643","article-title":"Long circulating polymeric nanoparticles for gene\/drug delivery","volume":"19","author":"Hu","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0730","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0735","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00914037.2017.1332623","article-title":"Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review","volume":"67","author":"Amoabediny","year":"2018","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0740","doi-asserted-by":"crossref","DOI":"10.1186\/s40643-017-0145-9","article-title":"Review on the current status of polymer degradation: a microbial approach","volume":"4","author":"Pathak","year":"2017","journal-title":"Bioresour. Bioprocess."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0745","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/jac\/dkq318","article-title":"Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice","volume":"65","author":"Destache","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0750","first-page":"2847","article-title":"Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD+ immune cells","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0755","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/QAD.0000000000000971","article-title":"Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy","volume":"30","author":"Li","year":"2016","journal-title":"Aids"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0760","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2009.04.004","article-title":"Enhanced antiviral activity of Acyclovir loaded into \u03b2-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles","volume":"137","author":"Cavalli","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0765","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.vaccine.2004.09.009","article-title":"Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex","volume":"23","author":"Rodrigo Garz\u00f3n","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0770","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.03.012","article-title":"Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles","volume":"340","author":"Kuo","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0775","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.2147\/IJN.S185806","article-title":"Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection","volume":"13","author":"Hu","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111260","article-title":"Polymeric nanoencapsulation of alpha interferon increases drug bioavailability and induces a sustained antiviral response in vivo","volume":"116","author":"Pedroso-Santana","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0785","article-title":"Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0790","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-809717-5.00006-3","article-title":"Polymeric micelles for drug targeting and delivery","author":"Amin","year":"2017","journal-title":"Nanotechnol. Based Approach. Target. Deliv. Drugs Genes"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0795","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1039\/C3RA47370H","article-title":"Polymeric micelles as drug delivery vehicles","volume":"4","author":"Ahmad","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0800","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13233-010-0802-8","article-title":"Preparation of multifunctional polymeric micelles for antiviral treatment","volume":"18","author":"Ahn","year":"2010","journal-title":"Macromol. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0805","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.colsurfb.2015.10.036","article-title":"Mucoadhesive thermo-responsive chitosan-g-poly(N-isopropylacrylamide) polymeric micelles via a one-pot gamma-radiation-assisted pathway","volume":"136","author":"Sosnik","year":"2015","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0810","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejps.2010.08.004","article-title":"Synthesis of Lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system","volume":"41","author":"Li","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.06.020","article-title":"Self-assembled drug delivery systems. Part 7: hepatocyte-targeted nanoassemblies of an adefovir lipid derivative with cytochrome P 450-triggered drug release","volume":"472","author":"Du","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0820","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/mabi.201500094","article-title":"Shell cross-linked polymeric micelles as camptothecin nanocarriers for anti-HCV therapy","volume":"15","author":"Jim\u00e9nez-Pardo","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0825","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.biomaterials.2010.11.082","article-title":"Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles","volume":"32","author":"Chiappetta","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/nnm.09.90","article-title":"Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailaibility","volume":"5","author":"Chiappetta","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0835","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/(SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO;2-K","article-title":"Dendrimers: from design to application - a progress report","volume":"38","author":"Fischer","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0840","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1021\/cr990116h","article-title":"Convergent dendrons and dendrimers: from synthesis to applications","volume":"101","author":"Grayson","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0845","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eurpolymj.2019.07.013","article-title":"Dendrimers and hyperbranched structures for biomedical applications","volume":"119","author":"Pedziwiatr-Werbicka","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118814","article-title":"Dendrimers in the context of nanomedicine","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0855","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1747-0285.2006.00454.x","article-title":"Influence of generation 2-5 of PAMAM dendrimer on the inhibition of tat peptide\/TAR RNA binding in HIV-1 transcription","volume":"68","author":"Wang","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0860","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/AAC.48.5.1614-1623.2004","article-title":"Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection","volume":"48","author":"Kensinger","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0865","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1","volume":"90","author":"Telwatte","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0870","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.nano.2015.03.008","article-title":"Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: recent trends and developments in HIV treatment\/therapy","volume":"11","author":"Sep\u00falveda-Crespo","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0875","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/AAC.47.12.3970-3972.2003","article-title":"Mannosyl glycodendritic structure inhibits DC-SIGN-mediated ebola virus infection in cis and in trans","volume":"47","author":"Lasala","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0880","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2008.04.002","article-title":"Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro","volume":"34","author":"Dutta","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0885","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejmech.2015.05.026","article-title":"HIV-1 antiviral behavior of anionic PPI metallo-dendrimers with EDA core","volume":"98","author":"Garc\u00eda-Gallego","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0890","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1086\/344316","article-title":"Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers","volume":"186","author":"Landers","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0895","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bmc.2009.06.035","article-title":"Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl \u03b1(2\u21923) lactose moieties as inhibitors for human influenza viruses","volume":"17","author":"Oka","year":"2009","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0900","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/1381612003400704","article-title":"Novel anti-RSV dianionic dendrimer-like compounds: design, synthesis and biological evaluation","volume":"6","author":"Gazumyan","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0905","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aid.2005.21.207","article-title":"SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in Macaques","volume":"21","author":"Jiang","year":"2005","journal-title":"AIDS Res. Hum. Retrovirus."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0910","first-page":"561","article-title":"VivaGelTM (SPL7013 Gel): a candidate dendrimer - microbicide for the prevention of HIV and HSV infection","volume":"2","author":"Rupp","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0915","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jmv.25928","article-title":"A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus","volume":"92","author":"Kandeel","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0920","series-title":"Antimicrob. Nanoarchitectonics From Synth. to Appl","first-page":"383","article-title":"Nanoparticles in antiviral therapy","author":"Milovanovic","year":"2017"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0925","article-title":"Metal nanoparticles: a promising treatment for viral and arboviral infections","author":"Maduray","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0930","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157016212803901383","article-title":"Gold nanoparticles as an HIV entry inhibitor","volume":"10","author":"Vijayakumar","year":"2014","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0935","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.3390\/molecules16108894","article-title":"Silver nanoparticles as potential antiviral agents","volume":"16","author":"Galdiero","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0940","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/1040841X.2013.879849","article-title":"Metal nanoparticles: the protective nanoshield against virus infection","volume":"42","author":"Rai","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0945","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2018-0089","article-title":"Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1","volume":"13","author":"Tavakoli","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0950","doi-asserted-by":"crossref","first-page":"100620","DOI":"10.1016\/j.nanoso.2020.100620","article-title":"Nano-based antiviral coatings to combat viral infections","volume":"24","author":"Basak","year":"2020","journal-title":"Nano Struct. Nano Objects"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0955","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081370","article-title":"Metal-based nanoparticles for the treatment of infectious diseases","volume":"22","author":"Aderibigbe","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0960","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/1040841X.2013.879849","article-title":"Metal nanoparticles: the protective nanoshield against virus infection","volume":"42","author":"Rai","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0965","first-page":"67","article-title":"Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis","volume":"4","author":"Oh","year":"2009","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0970","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1039\/C6RA25010F","article-title":"The inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivir","volume":"7","author":"Lin","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0975","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/nn302538y","article-title":"Hyaluronic acid-gold nanoparticle\/interferon \u03b1 complex for targeted treatment of hepatitis C virus infection","volume":"6","author":"Lee","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0980","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.msec.2018.04.005","article-title":"Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections","volume":"89","author":"Halder","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2019.113688","article-title":"Inhibition of herpes simplex virus type 1 by copper oxide nanoparticles","volume":"275","author":"Tavakoli","year":"2020","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jconrel.2021.08.011_bb0990","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0563-4","article-title":"Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine","volume":"26","author":"Ghaffari","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb0995","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1134\/S1995078010050174","article-title":"Interaction of titanium dioxide nanoparticles with influenza virus","volume":"5","author":"Mazurkova","year":"2010","journal-title":"Nanotechnol. Russ."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1000","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1039\/C7NR06520E","article-title":"Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection","volume":"9","author":"Yang","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1005","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1021\/es2000062","article-title":"Electrochemical multiwalled carbon nanotube filter for viral and bacterial removal and inactivation","volume":"45","author":"Vecitis","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1010","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181294","article-title":"Enhanced virus filtration in hybrid membranes with MWCNT nanocomposite","volume":"6","author":"N\u00e9meth","year":"2019","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227220","article-title":"Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation","volume":"14","author":"Dong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquaculture.2020.735434","article-title":"In vivo efficacy of ganciclovir by using single-walled carbon nanotubes as a drug carrier against infectious spleen and kidney necrosis virus in mandarin fish","volume":"526","author":"Zhao","year":"2020","journal-title":"Aquaculture"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.carbon.2016.09.032","article-title":"Carbon dots as inhibitors of virus by activation of type I interferon response","volume":"110","author":"Du","year":"2016","journal-title":"Carbon N. Y."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1030","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/acs.bioconjchem.8b00448","article-title":"Graphene quantum dots based systems as HIV inhibitors","volume":"29","author":"Iannazzo","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1035","article-title":"Carbon dots\u2019 antiviral functions against noroviruses","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1040","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.xphs.2020.06.019","article-title":"Drug delivery system targeting CD4+ T Cells for HIV-1 latency reactivation towards the viral eradication","volume":"109","author":"Jaimalai","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/2211738507666190829161737","article-title":"Effect of acyclovir solid lipid nanoparticles for the treatment of herpes simplex virus (HSV) Infection in an animal model of HSV-1 infection","volume":"7","author":"Kondel","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1050","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-018-0086-0","article-title":"Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates","volume":"3","author":"Bayon","year":"2018","journal-title":"Npj Vaccin"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1055","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.2147\/IJN.S241492","article-title":"Induction of robust immune responses by cpg-odn-loaded hollow polymeric nanoparticles for antiviral and vaccine applications in chickens","volume":"15","author":"Lin","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1060","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.2147\/IJN.S241702","article-title":"Antiviral activity of chitosan nanoparticles encapsulating curcumin against hepatitis C virus genotype 4a in human hepatoma cell lines","volume":"15","author":"Loutfy","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquaculture.2019.734377","article-title":"Anti-betanodavirus activity of isoprinosine and improved efficacy using carbon nanotubes based drug delivery system","volume":"512","author":"Zhu","year":"2019","journal-title":"Aquaculture"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jiac.2018.12.006","article-title":"Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus","volume":"25","author":"Kumar","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12090875","article-title":"Immunostimulating rna delivered by p1500 pegylated cationic liposomes limits influenza infection in c57bl\/6 mice","volume":"12","author":"Goncharova","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1080","doi-asserted-by":"crossref","DOI":"10.3390\/v11080732","article-title":"Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection","volume":"11","author":"Morris","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1085","article-title":"Glycyrrhizic-acid-based carbon dots with high antiviral activity by multisite inhibition mechanisms","volume":"16","author":"Tong","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155211","article-title":"Pt-, rh-, ru-, and cu-single-wall carbon nanotubes are exceptional candidates for design of anti-viral surfaces: a theoretical study","volume":"21","author":"Aasi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1095","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1100","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2010.06.121","article-title":"Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen","volume":"28","author":"Sl\u00fctter","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2009.06.006","article-title":"Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses","volume":"379","author":"Thomas","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jconrel.2006.06.020","article-title":"Stable cationic microparticles for enhanced model antigen delivery to dendritic cells","volume":"114","author":"Wischke","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biomaterials.2017.05.001","article-title":"Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies","volume":"136","author":"Courant","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.actbio.2015.12.026","article-title":"Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradation","volume":"32","author":"Andorko","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1125","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1021\/acsnano.5b07716","article-title":"Different-sized gold nanoparticle activator\/antigen increases dendritic cells accumulation in liver-draining lymph nodes and CD8+ T cell responses","volume":"10","author":"Zhou","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1130","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.nano.2016.01.021","article-title":"Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo","volume":"12","author":"Borrego","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1135","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2007.04.037","article-title":"Molecular basis for target RNA recognition and cleavage by human RISC","volume":"130","author":"Ameres","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1145","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1976","article-title":"A review on current status of antiviral siRNA","volume":"28","author":"Qureshi","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1150","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1160","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1039\/C6RA26472G","article-title":"Delivery of VP1 siRNA to inhibit the EV71 virus using functionalized silver nanoparticles through ROS-mediated signaling pathways","volume":"7","author":"Li","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13346-017-0426-z","article-title":"Inhibiting influenza virus replication and inducing protection against lethal influenza virus challenge through chitosan nanoparticles loaded by siRNA","volume":"8","author":"Jamali","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","article-title":"Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection","volume":"162","author":"Steinbach","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s13346-017-0368-5","article-title":"Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes","volume":"7","author":"Gu","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1180","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/AAC.02768-13","article-title":"Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic avian influenza A (H5N1) virus infection","volume":"58","author":"Khantasup","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1208\/s12248-016-9961-7","article-title":"Nanomedicines: from bench to bedside and beyond","volume":"18","author":"Havel","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2016.03.005","article-title":"Recent advances in RNAi-based strategies for therapy and prevention of HIV-1\/AIDS","volume":"103","author":"Swamy","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1195","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00705-018-3757-2","article-title":"Inhibition of dengue virus infection by small interfering RNAs that target highly conserved sequences in the NS4B or NS5 coding regions","volume":"163","author":"Villegas","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1200","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.09.049","article-title":"Formulated minimal-length synthetic small hairpin Rnas are potent inhibitors of hepatitis c virus in mice with humanized livers","volume":"146","author":"Ma","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 + cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mt.2008.245","article-title":"Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9","volume":"17","author":"Chen","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1215","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jgm.705","article-title":"Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients","volume":"7","author":"Macpherson","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1220","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.omtn.2017.07.002","article-title":"Anti-adenoviral artificial microRNAs expressed from AAV9 vectors inhibit human adenovirus infection in immunosuppressed syrian hamsters","volume":"8","author":"Schaar","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virol.2016.07.019","article-title":"Inhibition of influenza A virus matrix and nonstructural gene expression using RNA interference","volume":"497","author":"McMillen","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1230","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbrc.2008.09.040","article-title":"RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells","volume":"376","author":"Dash","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177935","article-title":"Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection","volume":"12","author":"Herrera-Carrillo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/cei.13287","article-title":"Novel approaches for the design, delivery and administration of vaccine technologies","volume":"196","author":"Wallis","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1255","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.vaccine.2011.01.009","article-title":"A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity","volume":"29","author":"Even-Or","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1260","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2020.1750247","article-title":"The cationic liposome CCS\/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88","author":"Even-Or","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1265","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1270","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.18388\/abp.2014_1875","article-title":"Virus-like particles as vaccine","volume":"61","author":"Chroboczek","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1280","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41422-020-00392-7","article-title":"A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice","volume":"30","author":"Lu","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1285","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/j.vaccine.2012.09.021","article-title":"Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity","volume":"30","author":"Gregory","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1290","series-title":"Moderna COVID-19 Vaccine EUA Fact Sheet for Health Care Providers","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1295","series-title":"Pfizer-BioNTech COVID-19 Vaccine Overview and Safety","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1300","series-title":"Vaxzevria (Previously COVID-19 Vaccine AstraZeneca)","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1310","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1315","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.addr.2021.01.002","article-title":"Nanocarrier vaccines for SARS-CoV-2","volume":"171","author":"Machhi","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1320","first-page":"1","article-title":"Guidance for industry: liposome drug products- chemistry manufacturing and controls","author":"Food","year":"2002","journal-title":"Hum. Pharmacokinet. Bioavail."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1325","series-title":"Guidance for Industry on Drug Products, Including Biological Products, That Contain Nanomaterials - Guidance for Indutry","author":"U.S. Department of Health and Human Services Food and Drug Administration","year":"2017"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2019.02.044","article-title":"Spray freeze drying: emerging applications in drug delivery","volume":"300","author":"Vishali","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1340","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.addr.2009.03.010","article-title":"Effects of nanomaterial physicochemical properties on in vivo toxicity","volume":"61","author":"Aillon","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1345","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104690","article-title":"Pulmonary toxicity of silver vapours, nanoparticles and fine dusts: a review","volume":"115","author":"Hadrup","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1350","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/tx800064j","article-title":"Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes","volume":"21","author":"Karlsson","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1355","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.progpolymsci.2013.06.001","article-title":"Synthetic biopolymer nanocomposites for tissue engineering scaffolds","volume":"38","author":"Okamoto","year":"2013","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2021.08.011_bb1360","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1039\/C8EN01409D","article-title":"Mechanism of the toxic action of cationic G5 and G7 PAMAM dendrimers in the cyanobacterium: Anabaena sp. PCC7120","volume":"6","author":"Tamayo-Belda","year":"2019","journal-title":"Environ. Sci. Nano"},{"key":"10.1016\/j.jconrel.2021.08.011_bb1365","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/03639045.2020.1821055","article-title":"Bridging the gap: academia, industry and FDA convergence for nanomaterials","volume":"46","author":"Shah","year":"2020","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592100417X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592100417X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:00:44Z","timestamp":1759161644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592100417X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":272,"alternative-id":["S016836592100417X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine based approaches for combating viral infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}